Publication:
The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

Simple item page
dc.contributor.authorsYildiz, Ramazan; Buyukberber, Suleyman; Koca, Dogan; Korai, Lokman; Ciltas, Aydin; Unal, Olcun Umit; Gumus, Mahmut; Ozdemir, Nuriye; Dane, Faysal; Berk, Veil; Kaplan, Mehmet Ali; Elkiran, Tamer; Boruban, Melih Cern; Coskun, Ugur; Aydin, Dincer; Uncu, Dogan; Ozkan, Metin; Isikdogan, Abdurrahman; Benekli, Mustafa
dc.date.accessioned2022-03-12T16:14:25Z
dc.date.accessioned2026-01-11T11:14:47Z
dc.date.available2022-03-12T16:14:25Z
dc.date.issued2013
dc.identifier.doidoiWOS:000335419603655
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/225353
dc.identifier.wosWOS:000335419603655
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume31

Files

Collections

Araştırma Çıktıları